Related by context. Frequent words. (Click for all words.) 80 FDA Accepts 79 Receives Orphan Drug Designation 77 Generic Version 77 Meets Primary Endpoint 76 FDA Clears 76 Patient Enrollment 76 Completes Enrollment 75 Announces FDA Clearance 75 Initiates Phase II 75 Improves Survival 74 Drug Candidate 74 Receives FDA Clearance 73 Presents Positive 72 Inhaled Insulin 72 Preclinical Data 72 Cholesterol Drug 72 Initiate Phase 72 Commences Phase 72 Receives Patent 71 Initiates Phase 71 Drug Shows Promise 71 Develop Novel 71 Pivotal Phase 71 Phase III Clinical Trial 71 Blood Thinner 71 Clinical Trial Results 71 Pivotal Phase III 71 Key Milestones 71 Positive Opinion 70 Purchase CIALIS Need 70 Single Dose 70 Vertex Pharmaceuticals Announces 70 k Clearance 69 Cervical Cancer Vaccine 69 FDA Clearance 69 Phase III Trial 69 Achieves Milestone 69 Announces Immediate Availability 69 Transcept Pharmaceuticals 69 Patent Infringement Lawsuit 69 Patent Covering 69 Significantly Improves 69 Pomerantz Law Firm 69 Patent Lawsuit 69 FDA Approves 68 Significantly Reduces 68 Regains Compliance 68 Metastatic Melanoma 68 MITTEILUNG UEBERMITTELT VON BUSINESS 68 Receives Positive 68 Smallpox Vaccine 68 Completes Tender Offer 68 Pivotal Study 68 CHEAP ONLINE PHARMACY LOW 68 Q1 Loss Narrows 68 Announces Stockholder Approval 67 Q2 Loss Narrows 67 Announces Initiation 67 Provides Guidance 67 Jumps Higher 67 Receives CE 67 Updates Guidance 67 Reduces Risk 67 Receives Notification 67 Flagship Product 67 Inc. NASDAQ QLTI 67 Prostate Cancer Patients 67 Pivotal Trial 67 Cold Medicines 67 Provides Shareholder 67 Recombinant Human 67 Files Shelf Registration Statement 67 Develop Next Generation 67 Secures Additional 67 Files Patent 67 Issues Guidance 67 Q2 Loss Widens 67 Files Patent Infringement 67 Shows Promise 67 Significantly Reduced 67 Q3 Loss Narrows 67 Study Demonstrates 66 submitted Biologics License 66 Significantly Improved 66 Cholesterol Drugs 66 Announces Dismissal 66 II Clinical Trial 66 Q3 Loss Widens 66 PRICE GREAT DISCOUNT FREE 66 Diet Pill 66 Patent Issued 66 Seeks Approval 66 Annual Meeting Date 66 Announces Issuance 66 Am J Obstet 66 Exclusive License 66 FDA Approval 66 BY RYAN ERNST 66 Shareholder Lawsuit 66 Receives Regulatory 66 Patent Dispute